Form 4: Century Therapeutics Director Quimi Daphne Buys 5,000 Shares

Director Quimi Daphne acquired 5,000 shares of Century Therapeutics (IPSC) at an average price of $1.5314 on September 12, 2024.

Summary

• On September 12, 2024, Quimi Daphne, a director of Century Therapeutics, Inc. (IPSC), purchased 5,000 shares of common stock.
• The shares were bought at a weighted average price of $1.5314, with individual prices ranging from $1.525 to $1.54.
• Following the transaction, Quimi Daphne directly owns 5,000 shares of Century Therapeutics.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the amount is relatively small and may not be highly significant.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's performance and future expectations. A director's purchase is generally viewed more positively than a sale.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates